Completed
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
NCT03442569
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States